Emicizumab prophylaxis to facilitate anticoagulant therapy for management of intra-atrial thrombosis in severe haemophilia with an inhibitor.

Weyand, Angela C; Dorfman, Adam L; Shavit, Jordan A; Pipe, Steven W

Weyand, Angela C; Dorfman, Adam L; Shavit, Jordan A; Pipe, Steven W.

Affiliation

Weyand AC; Department of Pediatrics, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.
Dorfman AL; Department of Pediatrics, Division of Cardiology, University of Michigan, Ann Arbor, Michigan.
Shavit JA; Department of Pediatrics, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.
Pipe SW; Department of Pediatrics, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.

Haemophilia ; 25(3): e203-e205, 2019 May.

Article in En | MEDLINE | ID: mdl-30866130

Subject(s)

Antibodies, Bispecific/pharmacology; Antibodies, Monoclonal, Humanized/pharmacology; Anticoagulants/therapeutic use; Heart Atria/drug effects; Hemophilia A/drug therapy; Hemophilia A/immunology; Thrombosis/complications; Thrombosis/prevention & control; Child; Hemophilia A/complications; Humans; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Antibodies, Bispecific / Antibodies, Monoclonal, Humanized / Heart Atria / Hemophilia A / Anticoagulants Limits: Child / Humans / Male Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google